Clinical Trials Directory

Trials / Completed

CompletedNCT02523573

Study of High Flow Nasal Cannula Oxygen for Bronchoscopy With Bronchoalveolar Lavage in ICU Patients

High Flow Nasal Oxygen for Bronchoscopy With Bronchoalveolar Lavage in Acute Respiratory Failure Patients: the OptiBAL Study.

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Hôpital Louis Mourier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bronchoscopy with bronchoalveolar lavage (BAL) is at risk for worsening hypoxemia in patients with acute respiratory failure (ARF). High-flow nasal cannula oxygen (HFNC) improves hypoxemia in ARF patients . We investigated its efficacy and tolerance in intensive care unit patients admitted for ARF requiring BAL.

Detailed description

Prospective, observational, multicenter study in ARF patients (minimal pulse oximetry -SpO2- of 92% with an minimal oxygen flow of 6 L/min , respiratory rate \> 25/min (20/min if use of accessory respiratory muscles) with a compatible etiology. Primary outcome measure is increase in ventilatory support (non-invasive positive pressure ventilation (NPPV) or endotracheal intubation (ETI)) within the first 24h following BAL.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdult ARF ICU patients needing BAL with HFNCbronchoalveolar lavage is performed in spontaneously breathing patients under high flow nasal cannula oxygen

Timeline

Start date
2011-11-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2015-08-14
Last updated
2016-02-26

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02523573. Inclusion in this directory is not an endorsement.